Peripheral odontogenic fibroma (POF) is the most prevalent benign oral tumor in dogs, accounting for 77.8% of all benign oral tumors and 2.8% of total biopsy submissions in veterinary pathology. While the prognosis is excellent with a cure rate approaching 95% following complete surgical excision—successful outcomes depend on accurately distinguishing POF from other gingival masses. For general practitioners, understanding its clinical features, diagnostic approach, and surgical considerations is key to effective case management.
The terminology surrounding oral masses in dogs has undergone significant evolution, creating both confusion and clarity in clinical practice. What practitioners once broadly categorized as “epulis” now requires precise histopathological diagnosis to ensure appropriate treatment planning. Among these lesions, peripheral odontogenic fibroma stands as the most frequently encountered benign oral tumor in canine patients, demanding comprehensive understanding of its clinical characteristics, diagnostic approach, and surgical management.
Current Classification and Nomenclature

The term “epulis” has been largely abandoned in modern veterinary pathology due to its non-specific nature¹. This Greek-derived term meaning “on the gum” fails to provide meaningful information about the biological behavior or treatment requirements of gingival masses. Contemporary veterinary oral pathology recognizes peripheral odontogenic fibroma (POF) as a distinct neoplastic entity, separate from reactive hyperplastic lesions such as focal fibrous hyperplasia. However, the nomenclature continues to evolve as our understanding of these lesions advances. According to Dr. Cindy Bell, the term POF may soon be replaced by “fibromatous hyperplasia of the gingival ligament (FHGL)” to better reflect that these common, benign gingival enlargements represent non-neoplastic proliferation of those connective tissues that anchor the gingiva to the tooth and bone³.
Recent comprehensive studies reveal that many lesions previously classified as fibromatous and ossifying epulides actually represent focal fibrous hyperplasia (68%) or peripheral odontogenic fibroma (28%)². This distinction carries significant clinical implications, as these conditions require different treatment approaches and have varying recurrence potentials. The proposed shift to FHGL terminology would further clarify the non-neoplastic nature of these lesions and their origin from the gingival ligament apparatus.
Epidemiology and Demographics
Prevalence and Frequency
Peripheral odontogenic fibroma demonstrates remarkable prevalence in veterinary practice. A large-scale UK-based study examining 35,328 biopsy submissions found POF prevalence of 2.8% (95% confidence interval: 2.7-3.0%), with a mean age at diagnosis of 8.1 ± 2.7 years³. More recent Swiss data confirms POF as the most common oral tumor, comprising 77.8% of all benign oral tumors⁴.
Sex and Neuter Status Predisposition
Males demonstrate 1.2 times greater odds of developing POF compared to females (odds ratio: 1.2, 95% CI: 1.1-1.4)³. Particularly significant is the finding that neutering associates with increased diagnostic risk (OR: 1.6, 95% CI: 1.3-1.9)³. In specialized referral populations, castrated males show substantial overrepresentation, with male-to-female ratios reaching 1.8:1⁵.

Breed Predisposition
Specific breeds demonstrate significantly elevated POF development risk compared to crossbred dogs. The highest-risk breeds include:
- Boxers (OR: 3.78, 95% CI: 2.80-5.09)
- Border Terriers (OR: 3.21, 95% CI: 2.10-4.91)
- Basset Hounds (OR: 3.18, 95% CI: 1.58-6.44)³
Additional breeds showing predisposition include Shetland Sheepdogs, Golden Retrievers, Akitas, and American Cocker Spaniels⁶. Notably, breeds with increased odds of multiple simultaneous POFs include Boxers (OR: 12.02), Border Terriers (OR: 5.05), and Staffordshire Bull Terriers (OR: 2.42)³.
Anatomical Distribution and Location Patterns

Regional Preferences
POF exhibits distinct anatomical predilections that inform both diagnosis and surgical planning. The rostral maxilla represents the most common location at 40.1% of cases, followed by the caudal mandible³. The maxillary-to-mandibular lesion ratio stands at 1.3:1 overall, but increases dramatically to 2.4:1 in cases presenting with multiple tumors³.
These distribution patterns align remarkably with human POF characteristics, where mandibular premolar and maxillary anterior regions predominate⁵. This anatomical consistency across species suggests fundamental biological factors influencing POF development in specific oral locations.
Pathogenesis and Histological Characteristics
Cellular Origin and Development
POF originates from periodontal ligament cells, distinguishing it from other gingival proliferative lesions⁷. Histopathologically, POF demonstrates proliferated fibroblasts within connective tissue, accompanied by proliferated odontogenic epithelium with variable amounts of osteoid, cementum, or dentin-like material⁸. The presence of isolated strands of odontogenic epithelium represents a defining diagnostic feature that differentiates POF from focal fibrous hyperplasia.
Hypercellular Variants
Recent investigations identify hypercellular POF variants characterized by increased spindle cell component density, reduced intervening stroma, and mitotic activity⁹. These variants, previously misclassified as odontogenic sarcomas, demonstrate benign behavior following complete surgical excision with no reported recurrences⁹.

Clinical Presentation and Diagnostic Evaluation

Physical Examination Findings
POF typically presents as slow-growing, localized gingival masses closely associated with teeth. The clinical appearance varies from smooth, pink, expansive growths to cauliflower-like proliferations⁸. Early lesions may appear as subtle gingival thickening, progressing to obvious masses that can interfere with normal occlusion.
Advanced Diagnostic Imaging
Diagnostic imaging plays crucial roles in POF evaluation and treatment planning. Intraoral radiography provides essential information about underlying bone involvement, though POF characteristically lacks bone invasion¹⁰. Computed tomography offers superior visualization for extensive lesions, providing precise anatomical delineation and treatment margins¹¹.
CT characteristics of odontogenic neoplasms reveal POF as contrast-enhancing extraosseous masses rarely requiring advanced imaging¹¹. When CT examination occurs, 25% of POF cases may not be visible on imaging, emphasizing the primarily soft tissue nature of these lesions¹¹.
Histopathological Diagnosis
Definitive POF diagnosis requires histopathological examination by pathologists experienced in oral pathology². POF demonstrates fibrous or fibromyxomatous proliferation containing variable amounts of odontogenic epithelium. The presence of both epithelial and mesenchymal elements classifies POF as a mixed epithelial/mesenchymal odontogenic tumor rather than purely mesenchymal neoplasm¹².
Differential Diagnosis
Focal Fibrous Hyperplasia
Focal fibrous hyperplasia represents the primary differential diagnosis for POF. FFH consists of dense fibrous connective tissue with mature, widely scattered fibroblasts in dense collagen matrix⁵. The critical distinguishing feature is the absence of odontogenic epithelium in FFH, while POF invariably contains epithelial rests².
Clinically, FFH secondary to chronic irritation appears commonly in brachycephalic breeds, particularly Boxers and Bulldogs, presenting as dome-like growths with smooth mucosal surfaces¹³. FFH demonstrates predilection for the rostral maxilla (57% of cases) with significantly less caudal maxillary involvement⁵.
Gingival Hyperplasia
Gingival hyperplasia most commonly affects Boxer Dogs, with additional predisposition in Bulldogs and Cocker Spaniels¹⁴. This condition results from cellular proliferation within gums responding to inflammation and bacterial presence, rather than true neoplastic transformation.
Other Odontogenic Tumors
Canine acanthomatous ameloblastoma requires differentiation through its characteristic invasive behavior and bone destruction patterns. Unlike POF, ameloblastoma demonstrates aggressive local invasion requiring more extensive surgical margins¹⁵.
Surgical Management and Treatment Protocols
Surgical Approach
The gold standard treatment for POF involves en bloc surgical excision of the tumor and associated teeth. This approach ensures complete removal of affected tissues while minimizing unnecessary excision of healthy structures⁸. Complete surgical excision with appropriate margins achieves nearly 95% effectiveness, though recurrence may occur with incomplete excision¹⁶.
Technical Considerations
Surgical technique requires meticulous attention to margin assessment and periodontal ligament removal. Following tumor and tooth extraction, thorough curettage of the alveolus using diamond burs removes remaining periodontal ligament fibers, ensuring complete elimination of potential recurrence sources⁸.
Closure typically employs 4-0 monocryl sutures in large dogs or 5-0 monocryl in smaller patients. The healing process generally progresses favorably, with incision sites healing within 10-14 days and sutures dissolving over 2-4 weeks¹⁶.
Alternative Approaches
For clients concerned about potential recurrence or when lesions involve substantial gingival areas, tooth extraction may not be mandatory¹⁰. Conservative excision without tooth removal carries acceptable recurrence risk in experienced hands, though quantified data remains limited¹⁰.
Margin Assessment
Clean surgical margins with absence of tumor cells at excision edges virtually eliminate recurrence potential⁷. Conversely, incomplete excision with positive margins creates variable recurrence risk, emphasizing the importance of adequate initial treatment⁷.
BEFORE

AFTER

Postoperative Management and Complications
Recovery Expectations
Dogs undergoing POF excision typically experience excellent postoperative outcomes with minimal appearance changes and significantly improved quality of life⁸. Blood-tinged saliva commonly occurs during the first 24-48 hours postoperatively, representing normal healing response¹⁶.
Dietary Modifications
Soft food diets are recommended throughout the healing period, particularly for caudal oral cavity excisions, to prevent healing disruption. Duration of dietary modification typically spans 2-4 weeks, corresponding to complete suture dissolution¹⁶.
Pain Management
Appropriate postoperative analgesia ensures patient comfort during recovery. Pain management protocols should follow established veterinary dental surgery guidelines, with careful attention to patient-specific factors and contraindications.
BEFORE

AFTER

Antimicrobial Considerations
Prophylactic Antibiotic Use
Current evidence-based recommendations discourage routine prophylactic antibiotic use for POF excision procedures¹⁷. The 2022 antimicrobial stewardship guidelines clearly state that systemic antimicrobials are usually not indicated for routine dental procedures or tooth extractions¹⁸.
Indications for Antimicrobial Therapy
Antimicrobial therapy becomes appropriate for patients with established infection signs including pain, swelling, purulent discharge, lymphadenopathy, or elevated white blood cell counts¹⁷. Additionally, immunocompromised patients or those with underlying systemic diseases may benefit from perioperative antimicrobial coverage.
Topical Antimicrobials
Local antimicrobial delivery offers significant benefits without systemic exposure concerns. Chlorhexidine gluconate 0.12% represents the gold standard topical antimicrobial, providing high substantivity through binding to oral tissues and bactericidal activity against oral pathogens¹⁷.
Prognosis and Long-term Outcomes
Recurrence Rates
Complete surgical excision yields excellent long-term outcomes with minimal recurrence risk when proper surgical margins are achieved⁷. The benign nature of POF ensures absence of metastatic potential, making local control the primary treatment objective.
Quality of Life Impact
Early intervention provides optimal prognosis, while delayed treatment may necessitate more extensive surgical procedures including partial mandibulectomy for complete excision⁸. Prompt diagnosis and treatment minimize patient discomfort and preserve maximum oral function.

Prevention and Risk Mitigation

Oral Hygiene Management
Daily home plaque control represents critical prevention for hyperplastic gingival conditions¹³. Comprehensive oral hygiene programs should include daily tooth brushing with veterinary-safe dentifrice, regular professional dental cleanings, and appropriate dental chews.
Environmental Modifications
Discontinuing access to excessively hard objects that may cause chronic gingival irritation helps prevent reactive hyperplastic lesions¹⁹. Appropriate chew toy selection promotes dental health while avoiding trauma-induced proliferative responses.
Clinical Decision-Making Framework
Diagnostic Approach
Every dog presenting with gingival masses requires comprehensive evaluation including bloodwork, thorough oral examination with photography and measurements, and complete intraoral dental radiography⁸. This systematic approach enables accurate diagnosis and appropriate treatment planning.
Treatment Planning Considerations
Treatment decisions should consider patient age, overall health status, lesion location and size, and client preferences regarding extent of intervention. Clear communication about treatment options, including conservative versus aggressive approaches, enables informed decision-making.
Follow-up Protocols
Regular postoperative monitoring ensures proper healing and early detection of any complications. Long-term oral health maintenance through routine dental care prevents development of additional gingival proliferative lesions.
The management of peripheral odontogenic fibroma exemplifies the importance of evidence-based veterinary dentistry combining accurate diagnosis, appropriate surgical intervention, and comprehensive aftercare. As the most common benign oral tumor in dogs, POF demands thorough understanding by veterinary practitioners to ensure optimal patient outcomes and client satisfaction.
Peripheral Odontogenic Fibroma Dogs: References
- Soukup, J. W., & Bell, C. M. (2014). Nomenclature and classification of odontogenic tumors – part 1: Historical review. Journal of Veterinary Dentistry, 31(4), 228-232. https://pubmed.ncbi.nlm.nih.gov/25631847/
- Stadler, C., & de Vries, C. (2021). The ins and outs of odontogenic proliferative lesions in dogs and cats. LABOKLIN Europe. https://laboklin.com/en/the-ins-and-outs-of-odontogenic-proliferative-lesions-in-dogs-and-cats/
- Sánchez-Castillo, M., Cheng, K., Williams, A., et al. (2023). Clinicopathological features of peripheral odontogenic fibromas in dogs and risk factors for their laboratory diagnosis. Journal of Small Animal Practice, 64(5), 265-275. https://pubmed.ncbi.nlm.nih.gov/36782367/
- Brehm, L., Vapniarsky, N., Berg, J., et al. (2025). A retrospective analysis of oral tumors in dogs in Switzerland identifies peripheral odontogenic fibroma and melanoma as the predominant tumor types. Journal of the American Veterinary Medical Association, 263(1), 45-54. https://avmajournals.avma.org/view/journals/javma/263/1/javma.24.06.0414.xml
- Fiani, N., Verstraete, F. J., Kass, P. H., & Cox, D. P. (2011). Clinicopathologic characterization of odontogenic tumors and focal fibrous hyperplasia in dogs: 152 cases (1995-2005). Journal of the American Veterinary Medical Association, 238(4), 495-500. https://avmajournals.avma.org/view/journals/javma/238/4/javma.238.4.495.xml
- VCA Animal Hospitals. (2024). Oral Tumors – Peripheral Odontogenic Fibromas. https://vcahospitals.com/know-your-pet/oral-tumors—peripheral-odontogenic-fibromas
- Animal Dental Specialist. (2022). Peripheral Odontogenic Fibroma (POF). https://animaldentalspecialist.com/peripheral-odontogenic-fibroma-pof/
- Veterinary Dentistry. (2024). Peripheral Odontogenic Fibroma and Epulis in Dog. https://veterinarydentistry.net/peripheral-odontogenic-fibroma-and-epulis-in-dog/
- Kim, I., Volker, M. K., Powers, B., & Sánchez, M. (2024). Non-invasive and Locally Invasive Hypercellular Peripheral Odontogenic Fibroma in 20 Dogs. Journal of Veterinary Dentistry, 41(2), 89-98. https://journals.sagepub.com/doi/abs/10.1177/08987564231187080
- Goldschmidt, S. (2024). It Is Not Called an Epulis Anymore. Today’s Veterinary Practice, 13(3), 22-28. https://todaysveterinarypractice.com/dentistry/small-animal-epulis/
- Arzi, B., Cissell, D. D., Verstraete, F. J., et al. (2013). Computed tomographic characteristics of odontogenic neoplasms in dogs. Veterinary Radiology & Ultrasound, 55(2), 147-158. https://pubmed.ncbi.nlm.nih.gov/24102949/
- Buchner, A., Merrell, P. W., & Carpenter, W. M. (2006). Relative frequency of peripheral odontogenic tumors: a study of 1088 cases from northern California and comparison to studies from other parts of the world. Journal of Oral Pathology & Medicine, 35(5), 267-271. https://pubmed.ncbi.nlm.nih.gov/16630293/
- Murphy, B. G., Bell, C. M., & Soukup, J. W. (2020). Veterinary Oral and Maxillofacial Pathology. Wiley Blackwell, 197-201.
- Lewis, J. R., & Reiter, A. M. (2005). Management of generalized gingival enlargement in a dog—Case report and review of the literature. Journal of Veterinary Dentistry, 22(3), 160-169. https://pubmed.ncbi.nlm.nih.gov/16295803/
- Vicari, E. D. (2017). Managing Oral Tumors in Dogs. DVM360. https://www.dvm360.com/view/avma-2017-managing-oral-tumors-in-dogs
- Animal Dental Specialist. (2024). Peripheral Odontogenic Fibroma and Epulis in Dog – Treatment and Recovery. https://veterinarydentistry.net/peripheral-odontogenic-fibroma-and-epulis-in-dog/
- Animal Dental Specialist. (2013). Antimicrobial Therapy for Veterinary Dental and Oral Surgical Procedures. https://animaldentalspecialist.com/antimicrobial-therapy-vet-dentistry/
- Davis, I. J. (2023). The Use of Antibiotics in Veterinary Dentistry. Today’s Veterinary Practice, 8(2), 18-25. https://todaysveterinarypractice.com/dentistry/antibiotics-in-veterinary-dentistry/
- Hollis, A. R., Bell, C., Verstraete, F. J., et al. (2021). Fibromatous epulis and peripheral odontogenic fibroma in horses. Equine Veterinary Education, 33(8), 398-403. https://beva.onlinelibrary.wiley.com/doi/full/10.1111/eve.13379